Moxifloxacin Sandoz

Moxifloxacin, the active ingredient in Moxifloxacin Sandoz, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of serious bacterial infections in adult patients, including pneumonia, sinusitis, bronchitis and skin infections.

GNH USA supplies Moxifloxacin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections of the respiratory and skin pathways. - Community‑acquired bacterial pneumonia: eradicates susceptible pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens disease course and prevents complications. - Skin and skin structure infections: eliminates causative bacteria and promotes wound healing.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, swelling, or hives. - Clostridioides difficile infection: severe colitis. - Hepatic toxicity: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before prescribing Moxifloxacin, clinicians should consider several safety factors. - Renal impairment: assess kidney function and adjust therapy if needed. - History of tendon disorders: avoid use in patients with prior tendon injury. - QT prolongation risk: monitor ECG in patients with cardiac risk factors. - Pregnancy and lactation: reserve for situations where benefits outweigh potential risks. - Concomitant medications: review for interactions that may increase toxicity. - Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Moxifloxacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other fluoroquinolones (e.g., ciprofloxacin): additive toxicity. - Antacids containing magnesium or aluminum: markedly reduce absorption. - Warfarin: increased anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Theophylline: elevated serum concentrations leading to toxicity. - Diabetes medications: possible alterations in blood glucose control.